Jones James bought CPIX
November 11, 2025 · Form 4 insider transaction
Jones James bought 16 shares of Cumberland Pharmaceuticals Inc. at $2.06 per share, a transaction worth $32.96. The trade was recorded as l under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 20 days after the transaction.
Direction
Acquired (buy-side)
Shares
16
Price
$2.06
Total value
$32.96
InsiderJones James
Role—
SecurityCommon Stock
Transaction codeL: L
Transaction dateNovember 11, 2025
Filing dateDecember 1, 2025
Shares owned after44,588
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.